Dr. Amanda Nickles Fader is a professor in the Johns Hopkins Hospital Department of Gynecology and Obstetrics and the Sidney Kimmel Cancer Center. She is the former fellowship director and division director of the Johns Hopkins Kelly Gynecologic Oncology Service and currently is Vice Chair of Gynecologic Surgical Operations and the Director of the Center for Rare Gynecologic Cancers. Additionally, she serves as the 2024-2025 President of the Society of Gynecologic Oncology. Dr. Fader received her undergraduate degree with highest distinction in music (violin performance) and pre-medicine from the University of Virginia. She earned her medical degree from the Medical College of Virginia, and completed her residency in obstetrics and gynecology at the Magee-Women’s Hospital of UPMC in Pittsburgh. Dr. Fader then underwent gynecologic oncology fellowship training at the Cleveland Clinic. She has co-authored more than 230 publications in peer-reviewed medical journals and is recognized as an expert in rare gynecologic tumors, clinical trials and quality and safety in surgery. She has a special interest in uterine serous carcinoma and low-grade serous carcinoma of the ovary and currently serves as the PI or co-PI of three international NRG Oncology clinical trials. Dr. Fader serves as a national board examiner in gynecologic oncology for the American Board of Obstetrics and Gynecology and Associate Editor of the Gynecologic Oncology journal is a member of the Rare Tumor and Uterine Corpus Committees of the NRG/Gynecologic Oncology Group. She is also co-founder of the Society of Gynecologic Oncology BRIDGES Program, a two-year longitudinal clinical trials and career development program for early-career oncologists. She has been the recipient of several research grants and awards for her research, including the Society of Gynecologic Oncology Innovations Award, the Best AAGL Paper in Minimally Invasive Gynecologic Oncology Surgery, a Department of Defense Ovarian Cancer Clinical Trials Academy Leadership Award, and National Cancer Institute Cervical SPORE grant. Dr. Fader is consistently recognized for clinical excellence on lists such as Baltimore magazine’s Top Docs and Castle Connolly’s Top Doctors, and is a recipient of the Top 10 Docs, Compassionate Doctors and Patient Choice Awards from Vitals.com. She has particular expertise with the surgical and medical management of uterine (endometrial), ovarian, cervical and vulvar cancers, as well as the treatment of women who are at high risk for developing a gynecologic malignancy. She has a special interest in caring for patients throughout the entire spectrum of their lives: from preventive oncology — minimizing key risk factors that can lead to gynecologic cancers — to survivorship initiatives addressing all aspects of recovery, including emotional well-being, sexual health and clinical follow-up. Dr. Fader is rated as an Advanced provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Ovarian Cancer, Bladder Reconstruction, and Hernia Surgery.

Akila Viswanathan, M.D., M.P.H., is the director for the Department of Radiation Oncology and Molecular Radiation Sciences, and a professor of radiation oncology, gynecology/obstetrics and oncology for Johns Hopkins University School of Medicine. Dr. Viswanathan leads the department emphasizing excellence in clinical care, research and education. She has expertise with gynecologic cancers and their treatment, including cervical and uterine cancers and image-guided brachytherapy. She has developed numerous clinical innovations and initiated several system-wide integration efforts at all sites, including Green Spring Station, Bayview, Johns Hopkins Hospital, Suburban's Rockledge site, and Sibley Memorial Hospital for the Johns Hopkins Department of Radiation Oncology. Dr. Viswanathan earned her undergraduate degree at Harvard University, her medical degree at the University of Pittsburgh School of Medicine, followed by her Masters in Public Health and Masters in Epidemiology at the Harvard School of Public Health. She completed a residency in radiation oncology at the Joint Center for Radiation Therapy at Harvard Medical School, where she served as chief resident. She has had research grant funding through the National Cancer Institute K07, R21 and R01 programs to support efforts in gynecologic cancers, specifically looking at the identification of gynecologic tumors at the time of brachytherapy under magnetic resonance imaging. The research team has developed several novel clinical innovations. Dr. Viswanathan has been named one of America's Top Doctors by Newsweek, Who’s who in America, and a Super Doctor by the Washington Post magazine. Dr. Viswanathan served as President and Chair of the Board of the American Brachytherapy Society; Chair of Education Committee for American Society for Radiation Oncology; and, on the Gynecologic Cancer Steering Committee and the uterine cancer task force for the National Cancer Institute. Dr. Akila Viswanathan has published more than 200 articles and chapters, and lectures nationally and internationally. She is the Editor-in-Chief for Seminars in Radiation Oncology. She is on the editorial board of Gynecologic Oncology and Brachytherapy, and is an editor of several textbooks including Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management, Radiation Therapy Techniques for Gynecologic Cancers, and Gunderson and Tepper's Clinical Radiation Oncology. Make A Gift. Dr. Viswanathan is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Vaginal Cancer, Cervical Cancer, Vulvar Cancer, Vulvectomy, and Cordotomy.

Stéphanie Gaillard is a medical oncologist who specializes in the treatment of gynecologic malignancies. She recently joined the faculty of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and is their Director of Gynecologic Cancer Trials. Dr. Gaillard earned her medical degree and doctoral degree in cancer biology from Duke University. Following medical school, she underwent residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes by incorporating promising new biologic, targeted, and immune therapies into standard treatment regimens. Her translational research program focuses on understanding the immune environment associated with gynecologic cancers and mechanisms of resistance to current therapies. Dr. Gaillard is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Tissue Biopsy, and Salpingo-Oophorectomy.

Dr. Rebecca Stone is an associate professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Her area of clinical expertise is gynecologic cancers, including cervical, uterine, vulvar and ovarian cancer, as well as gestational trophoblastic disease. Dr. Stone is a highly skilled surgeon with expertise in laparoscopic and robotic surgery for gynecologic tumors. She also serves as director of the Gynecology Enhanced Recovery after Surgery initiative, an innovative, multidisciplinary program that improves recovery and healing time after major abdominal surgery, as well as minimizes health care costs for patients. Dr. Stone received her undergraduate degree in biology from the University of Virginia. She earned her medical degree from the University of Virginia School of Medicine, where she subsequently completed her residency in obstetrics and gynecology. Dr. Stone performed a four-year gynecologic oncology fellowship at the University of Texas MD Anderson Cancer Center. She also earned a master’s degree in cancer biology from the University of Texas in 2010. Prior to joining Johns Hopkins, Dr. Stone was an assistant professor at the University of Arkansas for Medical Sciences, where she was one of five gynecologic oncologists serving the entire state. Dr. Stone is internationally recognized for her research pertaining to early diagnosis and treatment of ovarian cancer. She is widely published in the field of gynecologic oncology, with first-author papers in the New England Journal of Medicine and Lancet Oncology, as well as over 40 co-authored manuscripts in peer-reviewed medical journals. She was honored with an award for one of the most influential papers published in the field of obstetrics and gynecology in 2012 and with an Ovarian Cancer Research Fund Grant for “Unplugging Ovarian Cancer from the Power of Platelets.” Dr. Stone strongly believes in a multidisciplinary team approach to gynecologic cancer care. She seeks to provide women with the most advanced and personalized treatment plans while best preserving quality of life. She enjoys working with community providers so that patients are comforted by receiving care close to home. Dr. Stone is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Oophorectomy.

Kimberly Levinson, M.D., is an associate professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Her areas of clinical expertise include minimally invasive surgery with both robotic and single incision laparoscopy, ovarian cancer debulking, cervical cancer and dysplasia. Dr. Levinson received her undergraduate degree from Tufts University. She earned her M.D. from the Johns Hopkins University School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her medical residency at the Johns Hopkins University School of Medicine and performed a clinical fellowship in gynecologic oncology at Cleveland Clinic. Dr. Levinson has also completed international research at Preventive Oncology International in Peru and the School for International Training in Chile. Dr. Levinson joined the Johns Hopkins faculty in 2014. Her research interests include health care disparities in gynecologic tumors, cervical cancer prevention and treatment, and surgical innovation. She has published numerous manuscripts in gynecologic oncology involving these and other various research topics. Dr. Levinson is currently a principal investigator in the Specialized Program of Research Excellence (SPORE) in Cervical Cancer. In addition, she has a strong commitment to education, and she is the assistant director of the Johns Hopkins residency program and the associate director of the Gynecologic Oncology fellowship. Dr. Levinson is a member of the American College of Obstetricians and Gynecologists, the Society of Gynecologic Oncology, and the American Medical Association. Dr. Levinson was recognized with a Robert B. Hunt Award for Best Paper Published in the Journal of Minimally Invasive Gynecology in 2014. Dr. Levinson is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Endometrial Cancer, Testicular Yolk Sac Tumor, Ovarian Cancer, Hysterectomy, and Lymphadenectomy.

Paul Celano is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Celano is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. His top areas of expertise are Ovarian Cancer, Testicular Yolk Sac Tumor, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma.

Francis Grumbine is a Gynecologic Oncologist in Baltimore, Maryland. Dr. Grumbine is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. His top areas of expertise are Endometrial Cancer, Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Hysterectomy, and Hernia Surgery.

Dr. Armstrong works primarily in the area of women's malignancies, with a particular emphasis on breast cancer, ovarian cancer and other gynecologic malignancies, and the genetics of breast and ovarian cancer. She directs the medical gynecologic oncology clinical service and oversees therapeutic clinical trials in gynecologic cancers. Dr. Armstrong's clinical focus is on the development of new therapeutic approaches to the treatment of breast cancer and gynecologic malignancies. Particular areas of interest are intraperitoneal therapy in ovarian cancer and targeted biologic therapies. Dr. Armstrong also directs the Kimmel Cancer Center's Breast and Ovarian Cancer Screening Service, a genetic counseling service that focuses on identifying patients at risk for cancer and examination of new strategies for cancer screening and prevention. Dr. Armstrong has lectured locally, nationally and internationally. She is active in the Gynecologic Oncology Group, serving on the Medical Oncology, Developmental Therapeutics and Phase I GOG committees and as chair of several clinical trials through this group. She is a representative of the Southwest Oncology Group to the Gynecologic Cancer Steering Committee of the National Cancer Institute. Dr. Armstrong also serves as a representative of Johns Hopkins to the National Cooperative Cancer Network serving on the ovarian cancer and breast cancer risk reduction panels. She has participated as a member of the Cancer Working Group for the Office of Research on Women's Health for the National Institutes of Health, as a scientific reviewer for the breast and ovarian cancer research programs of the Department of Defense and the National Cancer Institute, as a reviewer for the NCI Special Emphasis Panel for Insight Awards to Stamp Out Breast Cancer and as a member of the NCI SPORE Program parent committee. Dr. Armstrong also is co-principal investigator for the NCI National Clinical Trials Network (NCTN) Lead Academic Participating Site (LAPS) at Johns Hopkins, now the major avenue for adult oncology clinical trials in the country. Recent work includes immune checkpoint inhibitor therapy in endometrial cancers with microsatellite instability and PARP inhibition in ovarian cancer. Dr. Armstrong is rated as an Experienced provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Testicular Yolk Sac Tumor, and Ovarian Cancer.

"Dr. Fariba Asrari is the director of Johns Hopkins Breast Center at Green Spring Station. She received her medical degree with honors from Shiraz Medical School in Iran and completed Internal medicine residency training at affiliated Hospitals of University of Pennsylvania in Philadelphia. She then completed her second residency training in Radiation Oncology at Hahnemann university in Philadelphia. She is an active member of the American Society for Therapeutic Radiology and Oncology as well as the American Medical Association, American Radium Society, Mid-Atlantic Society of Radiation Oncologists and American Society of Clinical Oncology. She is the treasurer of Mid-Atlantic Society of Radiation Oncologists. Dr. Asrari's special interest is in breast and gynecologic malignancies as well as skin cancer. She also participates in resident and medical student teaching. She is the recipient of 2006 Director's Teaching Award in Clinical Science at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and 2006 ""Teacher of The Year Award"" of Association of Residents in Radiation Oncology. She also has received 2005 Thomas Fercoit Memorial Professional of The Year Award from ""The ARC of Baltimore"" in appreciation of her dedicated care of individuals with developmental disabilities. Make A Gift". Dr. Asrari is rated as an Experienced provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Breast Cancer, Prostate Cancer, Merkel Cell Carcinoma, and Angiosarcoma.

Dr. Rima Jean Couzi is a cancer specialist in Towson, Maryland, caring for patients with breast cancer. Dr. Couzi earned her medical degree at the National University of Ireland. She completed residencies at St. Laurence's Hospital/Beaumont Hospitals and Galway Regional in Dublin, as well as Franklin Square Hospital in Baltimore. She performed a fellowship in medical oncology at St. Vincent's Hospital and St. James's Hospital in Dublin, and an additional fellowship in medical oncology at Johns Hopkins Oncology Center in Baltimore. She also earned a master’s degree in clinical epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Couzi joined the Johns Hopkins faculty in 2004. Dr. Couzi is a member of the American Society of Clinical Oncology and the Royal College of Physicians in Ireland. Selected Publications Antonarakis ES, Fradin JM, Petronis JD, Couzi RJ. “Not What It Seems.” Am J Med. 2007;120:408-411 Holdhoff M, Wung PK, Petronis J, Couzi R. “Persistent PET-positive liver lesions after successful chemotherapy in a patient with mediastinal seminoma.” J. Clin Oncol. 2007;25:2482-4. Li S, Couzi RJ, Thomas GH, Friedman AD, Borowitz MJ. “A novel variant three-way translocation of inversion 16 in a case of AML-M4eo following low dose methotrexate therapy.” Cancer Genet Cytogenet. 2001; 125:74-7. Schultz MJ, Tabb RD, Eagan JW, Citron JR, Couzi RJ. “Treating a male breast cancer patient with moderately differentiated, infiltrating ductal cancer of the breast.” Journal of Multidisciplinary Cancer Care. 2009 September – October. Siegelbaum MH, Citron JR, Eagan JW, Couzi RJ. “Treating a patient with Unfavorable-risk prostate cancer.” Journal of Multidisciplinary Cancer Care. 2009; July – August. Dr. Couzi is rated as an Experienced provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Dr. James Segars is director of the Division of Reproductive Science and Women’s Health Research and a professor in the Johns Hopkins Department of Gynecology and Obstetrics. He leads the Howard W. and Georgeanna Seegar Jones Laboratory of Reproductive Sciences and Women's Health Research, where he and his team focus on endometriosis, uterine fibroids, and reproductive and ovarian disorders. Dr. Segars received his undergraduate degree from Duke University and earned his M.D. from Duke University School of Medicine. He completed his residency in obstetrics and gynecology and a clinical fellowship in reproductive endocrinology at Vanderbilt University. Dr. Segars performed a postdoctoral fellowship at the Laboratory of Molecular Growth Regulation at the National Institute of Child Health and Human Development. He joined the Johns Hopkins faculty in 2015. Before coming to Johns Hopkins, Dr. Segars was head of the Unit on Reproductive Endocrinology and Infertility at the National Institute of Child Health and Human Development and a professor in the Department of Obstetrics and Gynecology at the Uniformed Services University of the Health Sciences. Dr. Segars has published more than 160 peer-reviewed research articles and serves on the editorial boards of Reproductive Sciences, Molecular Human Reproduction, Seminars in Reproductive Medicine, and Fertility and Sterility. Dr. Segars is rated as an Experienced provider by MediFind in the treatment of Endometrial Cancer. His top areas of expertise are Uterine Fibroids, Infertility, Endometriosis, Hysterectomy, and Intrauterine Device Insertion.

Otis Brawley is professor of oncology at the Johns Hopkins University School of Medicine and 39th Bloomberg Distinguished Professor at Johns Hopkins. Dr. Brawley leads a broad interdisciplinary research effort of cancer health disparities at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, working to close racial, economic and social disparities in the prevention, detection and treatment of cancer in the United States and worldwide. He also directs community outreach programs for underserved populations throughout Maryland as the Kimmel Cancer Center’s associate director for community outreach and engagement. A former professor of oncology and hematology and deputy director for cancer control at the Winship Cancer Institute at Emory University in Atlanta, Dr. Brawley is a member of the National Academy of Medicine and recently received the Martin D. Abeloff Award for Excellence in Public Health and Cancer Control from the Maryland State Council of Cancer Control. The award, named after the director of the Kimmel Cancer Center from 1992 until his death in 2007, was established to recognize advancements made in cancer control practices that influenced the field of public health on a statewide, national or global scale. A graduate of the University of Chicago’s Pritzker School of Medicine, he completed an internal medicine residency at University Hospitals of Cleveland, Case-Western Reserve University and a fellowship in medical oncology at the National Cancer Institute. Dr. Brawley is rated as an Experienced provider by MediFind in the treatment of Endometrial Cancer. His top areas of expertise are Prostate Cancer, Triple-Negative Breast Cancer, Breast Cancer, Prostatectomy, and Colonoscopy.

Fouad Abbas is an Obstetrics and Gynecologist in Baltimore, Maryland. Dr. Abbas is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Sertoli-Leydig Cell Tumor, Oophorectomy, and Ureteroscopy.

Okechukwu Ibeanu is an Obstetrics and Gynecologist and an Oncologist in Baltimore, Maryland. Dr. Ibeanu is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. His top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Neonatal Ovarian Cyst, Hysterectomy, and Oophorectomy. Dr. Ibeanu is currently accepting new patients.

Syed Nasir is a Hematologist and an Oncologist in Towson, Maryland. Dr. Nasir is rated as an Advanced provider by MediFind in the treatment of Endometrial Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast.

Fong W. Liu, M.D., M.P.H., is an assistant professor at the Johns Hopkins University School of Medicine. Her clinical expertise includes gynecologic oncology and general gynecology and obstetrics. Dr. Liu earned her Doctor of Medicine degree from the University of Alabama. She completed her residency in obstetrics and gynecology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr. Liu then went on to complete her fellowship in gynecologic oncology at the University of California, Irvine. Prior to joining Johns Hopkins, Dr. Liu served as an instructor in the department of obstetrics and gynecology at Beth Israel Deaconess Medical Center. Dr. Liu is also a gynecologic oncologist at the Sandra and Malcolm Berman Cancer Institute at GBMC. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Endometrial Cancer, Oophorectomy, and Hernia Surgery.

James Stuart Ferriss is an associate professor in the Johns Hopkins Department of Gynecology and Obstetrics and director of the F.J. Montz Gynecologic Oncology Fellowship Program. He is an expert in the care of women with cancers of the uterus, cervix, vulva, vagina, fallopian tubes and ovaries. Dr. Ferriss is passionate about minimally invasive approaches to surgery and has extensive experience with robotic surgery. Dr. Ferriss received his undergraduate and medical degrees from Louisiana State University. He then completed his residency in obstetrics and gynecology at the University of Texas Southwestern Medical Center and his fellowship in gynecologic oncology at the University of Virginia. Prior to joining Johns Hopkins, Dr. Ferriss was associate professor in the departments of women’s health and oncology at the University of Texas at Austin Dell Medical School. Before that, he was assistant professor in the department of obstetrics, gynecology and reproductive sciences at Temple University in Philadelphia. Dr. Ferriss’ research is focused on innovations in surgical and clinical education. Dr. Ferriss serves on a variety of boards and is a member of the Society of Gyneocologic Oncology, Mid-Atlantic Gynecologic Oncology Society, American Society of Clinical Oncology, the American College of Surgeons and the American Congress of Obstetricians and Gynecologists. He has been recognized with several awards and honors, including being named a top doctor for outstanding patient care. Dr. Ferriss’ passion for getting to know each of his patients’ values and personal treatment goals and empowering them to be active participants in their treatment defines his approach to patient care. Dr. Ferriss has special interest in supporting his patients through the entire arc of their cancer care from diagnosis to surgery, chemotherapy, and survivorship and palliative care. Videos Dr. Stuart FerrissGynecologic Oncologist Contact for Research Inquiries 600 N. Wolfe St Phipps 281 Baltimore, MD 21287 Research Summary Dr. Ferriss’ research currently focuses on increasing the diversity of patients recruited to clinical trials by understanding the factors and circumstances that prevent some patients from participating. He is also focused on innovations in surgical and clinical education. Dr. Ferriss is rated as an Advanced provider by MediFind in the treatment of Endometrial Cancer. His top areas of expertise are Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Ovarian Cancer, Oophorectomy, and Lymphadenectomy.

Dr. Robert Liddell is an Assistant Professor of Radiology and Surgery and Division Chief of Interventional Radiology at the Johns Hopkins School of Medicine. His specialty is interventional radiology, with an expertise in interventional oncology and vascular and interventional radiology. Dr. Liddell received his MBBCh at the Royal College of Surgeons in Ireland. He completed his residency at Johns Hopkins University School of Medicine in Diagnostic Radiology and his fellowship in Interventional Radiology. Videos Interventional Radiology. Dr. Liddell is rated as an Advanced provider by MediFind in the treatment of Endometrial Cancer. His top areas of expertise are Bile Duct Obstruction, Ascites, Fibrolamellar Carcinoma, Liver Embolization, and Pancreaticoduodenectomy.

Colleen McCormick, M.D., M.P.H., is an assistant professor in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine in Baltimore. Her areas of clinical expertise include gynecologic oncology with a focus on cervical and endometrial cancers, complex cancer cases and surgery for gynecologic cancers. A Baltimore native, Dr. McCormick received her undergraduate degree from Earlham College in Richmond, Virginia. Her advanced degrees include a doctorate in medicine and a Master of Public Health from Johns Hopkins. Dr. McCormick completed her residency as well as the F.J. Montz Fellowship in Gynecologic Oncology at The Johns Hopkins Hospital. She has significant clinical experience, initially in Portland, Oregon, where she was the medical director at Legacy Gynecologic Oncology. She was most recently at the University of New Mexico before returning home to Johns Hopkins and Baltimore. Her research interests include clinical trial programs, focusing on increasing diversity and inclusion in clinical trials. Deeply invested in patient experience, she recently served as a patient safety officer at the University of New Mexico, and she has researched practitioner and patient perspectives regarding endometrial cancer care. She has additional training in palliative care and genetic counseling, and she strongly values being able to accompany patients through their entire cancer journey. Dr. McCormick is a published author and has been invited to lecture both regionally and nationally. Dr. Mccormick is rated as an Advanced provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Virilizing Ovarian Tumor, Ovarian Cancer, Ovarian Carcinosarcoma, and Bladder Reconstruction.

Sankaravadivu Sivasailam is a Hematologist Oncology specialist and a Hematologist in Towson, Maryland. Dr. Sivasailam is rated as an Advanced provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Inflammatory Breast Cancer, and Angiosarcoma.